Alnylam Pharmaceuticals Inc
Open
SectorHealthcare
291.19 -0.55
Overview
Share price change
24h
Min
283.83
Max
292.93
Income | 20M 206M |
|---|---|
Sales | 70M 1.2B |
P/E Sector Avg | 73.592 49.052 |
EPS | 1.99 |
Profit margin | 17.649 |
Employees | 2,500 |
EBITDA | 7.1M 152M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +53.33% upside |
Next Earnings | 30 lip 2026 |
|---|
Market Cap | -2.2B 39B |
|---|---|
Previous open | 291.74 |
Previous close | 291.19 |
News Sentiment
By Acuity
50%
50%
154 / 344 Ranking in Healthcare
Alnylam Pharmaceuticals Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Alnylam Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 446.53 USD 53.33%
High 550 USD
Low 330 USD
Based on 20 Wall Street analysts offering 12 month price targets forAlnylam Pharmaceuticals Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$